Huang, Pingsheng <br/><br/>
Co-delivery of doxorubicin and (131)I by thermosensitive micellar-hydrogel for enhanced in situ synergetic chemoradiotherapy.  [electronic resource] 

 -  Journal of controlled release : official journal of the Controlled Release Society  Dec 2015 
 - 456-464 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-4995 
<br/><br/><label>Standard No.: </label>10.1016/j.jconrel.2015.11.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Chemoradiotherapy--methods<br/>Dose-Response Relationship, Drug<br/>Dose-Response Relationship, Radiation<br/>Doxorubicin--administration & dosage<br/>Drug Carriers<br/>Drug Compounding<br/>Female<br/>Hep G2 Cells<br/>Humans<br/>Hyaluronic Acid--administration & dosage<br/>Hydrogels<br/>Injections, Subcutaneous<br/>Iodine Radioisotopes--administration & dosage<br/>Liver Neoplasms--metabolism<br/>Mice, Inbred BALB C<br/>Mice, Inbred ICR<br/>Mice, Nude<br/>Micelles<br/>Polymers--chemistry<br/>Radiopharmaceuticals--administration & dosage<br/>Solubility<br/>Temperature<br/>Time Factors<br/>Tumor Burden